Metal-protein attenuating compounds and Alzheimer’s disease

Author： Ritchie Craig W   Bush Ashley I   Masters Colin L  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.12, 2004-12, pp. : 1585-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimer's Disease

By  

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3319-3327

Bentham Science Publishers

Access to resources Recommend Favorite

Metal-Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders

By  

Current Bioactive Compounds, Vol. 4, Iss. 2, 2008-08 ,pp. : 57-67

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products as Sources of New Lead Compounds for the Treatment of Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1864-1878

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite